All patients with COVID‐19 had their glucose levels strictly titrated with subcutaneous basal‐bolus insulin therapy in line with the ADA / AACE and Endocrine Society guidelines 8, 9 dealing with in hospital glucose control seriously ill patients (with avoidance of glycaemia less than), stopping all oral antidiabetic drugs for several considerations.